The development of more effective reversal agents are described in this review is an essential component of a tripartite strategy (Volkow and Collins, 2017) to reduce the biopsychosocial impact of opioid misuse in the “synthetic era”.
Section: Naloxone Narcan
Topic:
Buprenorphine
Medication for Opioid Use Disorder (MOUD)
Naloxone/Narcan
Medication for Opioid Use Disorder (MOUD)
Naloxone/Narcan
Setting:
Community-Based
Outpatient
Outpatient
Type: Best Practice/Policy/Guideline/Procedure